Apotea (APOTEA) - Total Liabilities
Based on the latest financial reports, Apotea (APOTEA) has total liabilities worth Skr1.26 Billion SEK (≈ $135.92 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Apotea (APOTEA) defensive interval to measure how many days the company can operate on defensive assets alone.
Apotea - Total Liabilities Trend (2021–2025)
This chart illustrates how Apotea's total liabilities have evolved over time, based on quarterly financial data. Check how resilient are Apotea's assets to evaluate the company's liquid asset resilience ratio.
Apotea Competitors by Total Liabilities
The table below lists competitors of Apotea ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Motic Xiamen Electric Group Co Ltd
SHE:300341
|
China | CN¥684.85 Million |
|
TPK Holding Co Ltd
TW:3673
|
Taiwan | NT$50.68 Billion |
|
Suzhou Chunqiu Electronic Technology Co Ltd Class A
SHG:603890
|
China | CN¥3.07 Billion |
|
Berliner Effektengesellschaft AG
F:BFV
|
Germany | €242.01 Million |
|
Astra Otoparts Tbk
JK:AUTO
|
Indonesia | Rp6.18 Trillion |
|
Healthcare Global Enterprises Limited
NSE:HCG
|
India | Rs-14.10 Billion |
|
Uniphar Group PLC
IR:UPR
|
Ireland | €1.19 Billion |
|
YCC CORP
KQ:232140
|
Korea | ₩122.69 Billion |
Liability Composition Analysis (2021–2025)
This chart breaks down Apotea's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Apotea total assets.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.40 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.33 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.57 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Apotea's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Apotea (2021–2025)
The table below shows the annual total liabilities of Apotea from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Skr1.12 Billion ≈ $120.59 Million |
+1155.53% |
| 2024-12-31 | Skr89.25 Million ≈ $9.61 Million |
-0.98% |
| 2023-12-31 | Skr90.14 Million ≈ $9.70 Million |
-89.96% |
| 2022-12-31 | Skr897.50 Million ≈ $96.59 Million |
+31.02% |
| 2021-12-31 | Skr684.99 Million ≈ $73.72 Million |
-- |
About Apotea
Apotea AB (publ) operates an online pharmacy in Sweden. The company offers products in the areas of allergy, face, baby, child and parent, bite and sting, preparedness, animal, fever and aches, cold, home and household, aid, hair removal and shaving, hair care, hands and feet, intimate, and dietary supplements. It also provides products in the categories of body care, stomach and intestine, food … Read more